Meta-analysis links high acute glycemic variability to increased short-term mortality in subarachnoid hemorrhage patients
This meta-analysis examined the relationship between acute glycemic variability and short-term mortality in adult patients hospitalized with subarachnoid hemorrhage. The analysis included 10,119 patients and utilized random-effects models to account for heterogeneity across studies. The primary outcome assessed was mortality within 90 days of the event.
The pooled results demonstrated that high acute glycemic variability was significantly associated with increased short-term mortality. The overall odds ratio was 1.64, with a 95% confidence interval of 1.34 to 2.01. Approximately 2,485 patients, representing 24.6% of the cohort, died within 90 days.
Subgroup analysis revealed that the association was stronger for patients with glucose monitoring lasting more than three days compared to those monitored for three days or less. The odds ratio was 2.62 for the longer monitoring duration versus 1.48 for the shorter duration. The p-value for this subgroup difference was 0.03. Safety data, adverse events, and discontinuations were not reported in the source material. Funding sources and conflicts of interest were not reported. The authors note that prolonged glucose monitoring may enhance prognostic value, but causation cannot be inferred from these pooled observational results.